Nuwiq
Payments companies reported to CMS as associated with Nuwiq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nuwiq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nuwiq
These are the largest totals companies reported as associated with Nuwiq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $58,355.14 |
| Craig Kessler | Washington, DC | Hematology & Oncology | $41,830.00 |
| Robert Sidonio | Atlanta, GA | Pediatric Hematology-Oncology | $26,014.14 |
| Fernando Corrales-Medina | Miami, FL | Pediatric Hematology-Oncology | $10,736.83 |
| Oya Tugal | Hawthorne, NY | Pediatric Hematology-Oncology | $7,807.08 |
| Nathan Connell | Boston, MA | Hematology (Internal Medicine) | $7,365.71 |
| Lisa Boggio | Chicago, IL | Hematology & Oncology | $7,343.21 |
| Akshat Jain | Redlands, CA | Pediatric Hematology-Oncology | $6,630.37 |
| Maureane Hoffman | Durham, NC | Blood Banking & Transfusion Medicine | $5,386.84 |
| Jill Johnsen | Seattle, WA | Hematology & Oncology | $5,001.24 |
Prescribed Nuwiq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.